These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9205096)

  • 21. Detection and characterization of the protein encoded by the chicken c-rel protooncogene.
    Simek S; Rice NR
    Oncogene Res; 1988; 2(2):103-19. PubMed ID: 2851122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mutant Rel-homology domain promotes transcription by p50/NFkappaB1.
    Xu X; Gélinas C
    Oncogene; 1997 Apr; 14(13):1521-30. PubMed ID: 9129142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of c-Rel to STAT5 target sequences in HTLV-I-transformed T cells.
    Sun SC; Maggirwar SB; Harhaj EW; Uhlik M
    Oncogene; 1999 Feb; 18(7):1401-9. PubMed ID: 10050877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viral rel and cellular rel associate with cellular proteins in transformed and normal cells.
    Morrison LE; Kabrun N; Mudri S; Hayman MJ; Enrietto PJ
    Oncogene; 1989 Jun; 4(6):677-83. PubMed ID: 2543940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The v-rel oncogene encodes a cell-specific transcriptional activator of certain promoters.
    Gélinas C; Temin HM
    Oncogene; 1988 Oct; 3(4):349-55. PubMed ID: 2856247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Back-mutation of the V-Ets to the C-Ets carboxy-terminal amino acids in the P135gag-myb-ets results in chicken neuroretina cells transformation and loss of basic fibroblast growth factor responsiveness.
    Garrido C; Leprince D; Plaza S; Aumercier M; Stéhelin D; Saule S
    Oncogene; 1996 Apr; 12(7):1449-56. PubMed ID: 8622861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discreet mutations from c-Rel to v-Rel alter kappaB DNA recognition, IkappaBalpha binding, and dimerization: implications for v-Rel oncogenicity.
    Phelps CB; Ghosh G
    Oncogene; 2004 Feb; 23(6):1229-38. PubMed ID: 14961076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.
    Starczynowski DT; Trautmann H; Pott C; Harder L; Arnold N; Africa JA; Leeman JR; Siebert R; Gilmore TD
    Oncogene; 2007 Apr; 26(19):2685-94. PubMed ID: 17072339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a NF-kappaB site in the negative regulatory element (epsilon-NRAII) of human epsilon-globin gene and its binding protein NF-kappaB p50 in the nuclei of K562 cells.
    Hou CH; Huang J; Qian RL
    Cell Res; 2002 Mar; 12(1):79-82. PubMed ID: 11942414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cooperative binding and synergistic activation by RelA and C/EBPbeta on the intercellular adhesion molecule-1 promoter.
    Catron KM; Brickwood JR; Shang C; Li Y; Shannon MF; Parks TP
    Cell Growth Differ; 1998 Nov; 9(11):949-59. PubMed ID: 9831247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the carboxy terminus of v-Rel in transformation and activation of endogenous gene expression.
    Smardova J; Walker A; Morrison LE; Kabrun N; Enrietto PJ
    Oncogene; 1995 May; 10(10):2017-26. PubMed ID: 7761102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear factor-kappaB/Rel blocks transforming growth factor beta1-induced apoptosis of murine hepatocyte cell lines.
    Arsura M; FitzGerald MJ; Fausto N; Sonenshein GE
    Cell Growth Differ; 1997 Oct; 8(10):1049-59. PubMed ID: 9342183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views.
    Chen FE; Ghosh G
    Oncogene; 1999 Nov; 18(49):6845-52. PubMed ID: 10602460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo evolution of c-rel oncogenic potential.
    Hrdlicková R; Nehyba J; Humphries EH
    J Virol; 1994 Apr; 68(4):2371-82. PubMed ID: 8139023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the c-rel and c-myc proto-oncogenes in avian tissues.
    Moore BE; Bose HR
    Oncogene; 1989 Jul; 4(7):845-52. PubMed ID: 2666905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinctions between c-Rel and other NF-kappaB proteins in immunity and disease.
    Liou HC; Hsia CY
    Bioessays; 2003 Aug; 25(8):767-80. PubMed ID: 12879447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic and opposing regulation of the stress-responsive gene IEX-1 by p53, c-Myc, and multiple NF-kappaB/rel complexes.
    Huang YH; Wu JY; Zhang Y; Wu MX
    Oncogene; 2002 Oct; 21(44):6819-28. PubMed ID: 12360408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional regulation by the carboxyl terminus of c-Myb depends upon both the Myb DNA-binding domain and the DNA recognition site.
    Dubendorff JW; Lipsick JS
    Oncogene; 1999 Jun; 18(23):3452-60. PubMed ID: 10376523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation.
    Rödel F; Hantschel M; Hildebrandt G; Schultze-Mosgau S; Rödel C; Herrmann M; Sauer R; Voll RE
    Int J Radiat Biol; 2004 Feb; 80(2):115-23. PubMed ID: 15164793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
    Sovak MA; Bellas RE; Kim DW; Zanieski GJ; Rogers AE; Traish AM; Sonenshein GE
    J Clin Invest; 1997 Dec; 100(12):2952-60. PubMed ID: 9399940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.